Vivos (RDGL) EBIT Growth (1y) (2011 - 2025)
Vivos (RDGL) EBIT Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -20.56% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 11.83% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -11.06% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 19.54% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 20.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 74.18% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 90.95% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -18.12% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 46.60% |
| 10 | Vivos | - | - | -3,105.00 | -65.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -65.57% |
| Sep 30, 2025 | 37.02% |
| Jun 30, 2025 | -29.19% |
| Mar 31, 2025 | -49.63% |
| Dec 31, 2024 | 29.80% |
| Sep 30, 2024 | -22.62% |
| Jun 30, 2024 | 42.88% |
| Mar 31, 2024 | -132.42% |
| Dec 31, 2023 | -33.61% |
| Sep 30, 2023 | -148.18% |
| Jun 30, 2023 | -16.11% |
| Mar 31, 2023 | 66.78% |
| Dec 31, 2022 | -223.04% |
| Sep 30, 2022 | -42.39% |
| Jun 30, 2022 | 57.52% |
| Mar 31, 2022 | -217.96% |
| Dec 31, 2021 | 26.02% |
| Sep 30, 2021 | -51.50% |
| Jun 30, 2021 | -1,343.08% |
| Mar 31, 2021 | -95.30% |